原发性肾小球基底膜相关肾病遗传背景与诊治

doi:10.12372/jcp.2022.22e1257

Abstract

Abstract:

Glomerular basement membrane (GBM) is an important component of the glomerular filtration barrier. Variations in various genes encoding GBM-related proteins may lead to structural and functional abnormalities in GBM, resulting in a variety of primary glomerular diseases, such as Alport syndrome and Pierson syndrome. Insufficient clinical understanding of GBM-related diseases can lead to misdiagnosis and underdiagnosis. In this article, we will elaborate on the genetic background of primary GBM and the progress of treatment of its related diseases to improve clinicians' understanding of these diseases.

Key words: glomerular basement membrane, genetic background, renal disease, child

KUANG Xinyu. Genetic background, diagnosis and treatment of glomerular basement membrane-associated kidney disease[J].Journal of Clinical Pediatrics, 2022, 40(12): 894-898.

Figures/Tables 1

References 28

[1]	Chew C, Lennon R. Basement membrane defects in genetic kidney diseases[J]. Front Pediatr, 2018, 6: 11. doi: 10.3389/fped.2018.00011 pmid: 29435440
[2]	Borza DB. Glomerular basement membrane heparan sulfate in health and disease: a regulator of local complement activation[J]. Matrix Biol, 2017, 57-58: 299-310.
[3]	Naylor RW, Morais MRPT, Lennon R. Complexities of the glomerular basement membrane[J]. Nat Rev Nephrol, 2021, 17(2): 112-127. doi: 10.1038/s41581-020-0329-y
[4]	Aumailley M. Laminins and interaction partners in the architecture of the basement membrane at the dermal-epidermal junction[J]. Exp Dermatol, 2021, 30(1): 17-24. doi: 10.1111/exd.14239 pmid: 33205478
[5]	Togawa H, Nakanishi K, Mukaiyama H, et al. First Japanese case of Pierson syndrome with mutations in LAMB2[J]. Pediatr Int, 2013, 55(2): 229-231. doi: 10.1111/j.1442-200X.2012.03629.x
[6]	Funk SD, Lin MH, Miner JH. Alport syndrome and Pierson syndrome: diseases of the glomerular basement membrane[J]. Matrix Biol, 2018, 71-72: 250-261.
[7]	Cosgrove D, Liu S. Collagen IV diseases: a focus on the glomerular basement membrane in Alport syndrome[J]. Matrix Biol, 2017, 57-58: 45-54.
[8]	Cummings CF, Pedchenko V, Brown KL, et al. Extra-cellular chloride signals collagen IV network assembly during basement membrane formation[J]. J Cell Biol, 2016, 213(4): 479-494. doi: 10.1083/jcb.201510065
[9]	Quinlan C, Rheault MN. Genetic basis of type IV collagen disorders of the kidney[J]. Clin J Am Soc Nephrol, 2021, 16(7): 1101-1109. doi: 10.2215/CJN.19171220
[10]	Kashtan CE, Ding J, Garosi G, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group[J]. Kidney Int, 2018, 93(5): 1045-1051. doi: S0085-2538(18)30085-1 pmid: 29551517
[11]	Zhang JL, Richetti S, Ramezani T, et al. Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2[J]. Matrix Biol, 2022, 112: 132-154. doi: 10.1016/j.matbio.2022.08.009
[12]	Wnuk M, Anderegg MA, Graber WA, et al. Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney[J]. Kidney Int, 2017, 91(4): 868-879. doi: S0085-2538(16)30609-3 pmid: 27988210
[13]	Darbro BW, Mahajan VB, Gakhar L, et al. Mutations in extracellular matrix genes NID1 and LAMC1 cause autosomal dominant Dandy-Walker malformation and occipital cephaloceles[J]. Hum Mutat, 2013, 34(8): 1075-1079. doi: 10.1002/humu.22351
[14]	Lin PY, Hung JH, Hsu CK, et al. A novel pathogenic HSPG2 mutation in Schwartz-Jampel syndrome[J]. Front Neurol, 2021, 12: 632336. doi: 10.3389/fneur.2021.632336
[15]	Xia P, Xie F, Zhou ZJ, et al. Novel LG1 mutations in agrin causing congenital myasthenia syndrome[J]. Intern Med, 2022, 61(6): 887-890. doi: 10.2169/internalmedicine.7774-21
[16]	Chen Z, Migeon T, Verpont MC, et al. HANAC syndrome Col4a1 mutation causes neonate glomerular hyperpermeability and adult glomerulocystic kidney disease[J]. J Am Soc Nephrol, 2016, 27(4): 1042-1054. doi: 10.1681/ASN.2014121217
[17]	Savige J, Harraka P. Pathogenic LAMA5 variants and kidney disease[J]. Kidney360, 2021, 2(12): 1876-1879. doi: 10.34067/KID.0007312021
[18]	Nozu K, Nakanishi K, Abe Y, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome[J]. Clin Exp Nephrol, 2019, 23(2): 158-168. doi: 10.1007/s10157-018-1629-4 pmid: 30128941
[19]	Shan LD, Peng J, Xiao H, et al. Clinical features and COL4A1 genotype of a toddler with hereditary angiopathy with nephropathy, aneurysms and muscle cramps syndrome[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2019, 21(8): 754-760.
[20]	Kulali F, Calkavur S, Basaran C, et al. A new mutation associated with Pierson syndrome[J]. Arch Argent Pediatr, 2020, 118(3): e288-e291.
[21]	Kamiyoshi N, Nozu K, Fu XJ, et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome[J]. Clin J Am Soc Nephrol, 2016, 11(8): 1441-1449. doi: 10.2215/CJN.01000116
[22]	Savige J, Lipska-Zietkiewicz BS, Watson E, et al. Guidelines for genetic testing and management of Alport syndrome[J]. Clin J Am Soc Nephrol, 2022, 17(1): 143-154. doi: 10.2215/CJN.04230321
[23]	Kashtan CE. Alport syndrome: achieving early diagnosis and treatment[J]. Am J Kidney Dis, 2021, 77(2): 272-279. doi: 10.1053/j.ajkd.2020.03.026 pmid: 32712016
[24]	Kashtan CE, Gross O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020[J]. Pediatr Nephrol, 2021, 36(3): 711-719. doi: 10.1007/s00467-020-04819-6 pmid: 33159213
[25]	Warady BA, Agarwal R, Bangalore S, et al. Alport syndrome classification and management[J]. Kidney Med, 2020, 2(5): 639-649. doi: 10.1016/j.xkme.2020.05.014
[26]	Torra R, Furlano M. New therapeutic options for Alport syndrome[J]. Nephrol Dial Transplant, 2019, 34(8): 1272-1279. doi: 10.1093/ndt/gfz131
[27]	Yamamura T, Horinouchi T, Adachi T, et al. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5[J]. Nat Commun, 2020, 11(1): 2777. doi: 10.1038/s41467-020-16605-x
[28]	Lin MH, Miller JB, Kikkawa Y, et al. Laminin-521 Protein therapy for glomerular basement membrane and podocyte abnormalities in a model of pierson syndrome[J]. J Am Soc Nephrol, 2018, 29(5): 1426-1436. doi: 10.1681/ASN.2017060690

GBM定位	致病基因	疾病	遗传方式	临床表型	进展至ESRD风险
Ⅳ型胶原蛋白	COL4A1^[16]	HANAC 综合征	常染色体显性	脑、眼、肌肉、肾脏（血尿、轻度蛋白尿、肾囊肿、肾衰竭）	成人后进入ESRD
Ⅳ型胶原蛋白	COL4A3/4/5/6^[10]	Alport综合征	常染色体/X连锁显性/双基因	肾脏（血尿、蛋白尿、进行性肾功能下降）、眼、耳	XLAS男性、ARAS、COL4A5/COL4A3或A4男性、COL4A3/4反式排列者100%进入ESRD
层粘连蛋白	LAMB2^[5]	PIERS/NS	常染色体隐性	脑、眼、肾脏（蛋白尿、镜下血尿、肾功能异常）/肾外表现少	婴儿期进展至ESRD/不足1/3患者婴幼儿期进展至ESRD
层粘连蛋白	LAMA5^[17]	原发性NS/激素耐药性肾病综合征	常染色体隐性	眼、骨骼、肌肉、呼吸道、肾脏（囊肿、蛋白尿、肾发育不良）	肾功能基本正常，个例报道进展至ESRD
巢蛋白	NID1^[13]	ADDWOC	常染色体显性	脑、头皮、癫痫，无肾脏表型报道	-
硫酸肝素蛋白多糖	AGRN ^[15]	先天性肌无力综合征	常染色体隐性	骨骼肌，无肾脏表型报道	-
硫酸肝素蛋白多糖	HSPG2^[14]	Schwartz-Jampel综合征1型	常染色体隐性	骨骼、肌肉、眼、耳、智力、睾丸，无肾脏表型报道	-

Genetic background, diagnosis and treatment of glomerular basement membrane-associated kidney disease

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28.
[2]	LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34.
[3]	ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55.
[4]	JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13.
[5]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[6]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[7]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[8]	ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804.
[9]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[10]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[11]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[12]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[13]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[14]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[15]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.